These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32699356)

  • 1. Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.
    Li Y; Li B; Li W; Wang Y; Akgül S; Treisman DM; Heist KA; Pierce BR; Hoff B; Ho CY; Ferguson DO; Rehemtulla A; Zheng S; Ross BD; Li JZ; Zhu Y
    Nat Commun; 2020 Jul; 11(1):3669. PubMed ID: 32699356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma.
    Akgül S; Li Y; Zheng S; Kool M; Treisman DM; Li C; Wang Y; Gröbner S; Ikenoue T; Shen Y; Camelo-Piragua S; Tomasek G; Stark S; Guduguntla V; Gusella JF; Guan KL; Pfister SM; Verhaak RGW; Zhu Y
    Cell Rep; 2018 Jul; 24(2):463-478.e5. PubMed ID: 29996106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.
    Abou-El-Ardat K; Seifert M; Becker K; Eisenreich S; Lehmann M; Hackmann K; Rump A; Meijer G; Carvalho B; Temme A; Schackert G; Schröck E; Krex D; Klink B
    Neuro Oncol; 2017 Apr; 19(4):546-557. PubMed ID: 28201779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
    Williams EA; Miller JJ; Tummala SS; Penson T; Iafrate AJ; Juratli TA; Cahill DP
    Acta Neuropathol Commun; 2018 Oct; 6(1):106. PubMed ID: 30333046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex.
    Gkountakos A; Pilotto S; Mafficini A; Vicentini C; Simbolo M; Milella M; Tortora G; Scarpa A; Bria E; Corbo V
    Carcinogenesis; 2018 Jul; 39(8):971-980. PubMed ID: 29955840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
    Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA
    Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
    Acquaviva J; Jun HJ; Lessard J; Ruiz R; Zhu H; Donovan M; Woolfenden S; Boskovitz A; Raval A; Bronson RT; Pfannl R; Whittaker CA; Housman DE; Charest A
    Cancer Res; 2011 Dec; 71(23):7198-206. PubMed ID: 21987724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
    Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of gliomas arising in patients with multiple sclerosis.
    Khalil A; Serracino H; Damek DM; Ney D; Lillehei KO; Kleinschmidt-DeMasters BK
    J Neurooncol; 2012 Sep; 109(2):261-72. PubMed ID: 22547311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation.
    Peterziel H; Müller J; Danner A; Barbus S; Liu HK; Radlwimmer B; Pietsch T; Lichter P; Schütz G; Hess J; Angel P
    Neuro Oncol; 2012 Apr; 14(4):426-39. PubMed ID: 22394497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary Trajectories of IDH
    Körber V; Yang J; Barah P; Wu Y; Stichel D; Gu Z; Fletcher MNC; Jones D; Hentschel B; Lamszus K; Tonn JC; Schackert G; Sabel M; Felsberg J; Zacher A; Kaulich K; Hübschmann D; Herold-Mende C; von Deimling A; Weller M; Radlwimmer B; Schlesner M; Reifenberger G; Höfer T; Lichter P
    Cancer Cell; 2019 Apr; 35(4):692-704.e12. PubMed ID: 30905762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
    Waldron JS; Yang I; Han S; Tihan T; Sughrue ME; Mills SA; Pieper RO; Parsa AT
    J Clin Neurosci; 2010 Dec; 17(12):1543-7. PubMed ID: 20822910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
    Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
    J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas.
    Chiang GC; Pisapia DJ; Liechty B; Magge R; Ramakrishna R; Knisely J; Schwartz TH; Fine HA; Kovanlikaya I
    J Neuroimaging; 2020 Nov; 30(6):901-909. PubMed ID: 32721076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.